Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Anticancer Research|November 2, 2010
Metronomic oral cyclophosphamide prednisolone chemotherapy is an effective treatment for metastatic hormone-refractory prostate cancer after docetaxel failureSylvain Ladoire, Jean Christophe Eymard, Sylvie Zanetta, et al.
American Journal of Clinical Oncology|June 7, 2007
Docetaxel plus gemcitabine in recurrent and/or metastatic squamous cell carcinoma of the head and neck: a phase II multicenter studyJean-Luc Labourey, Didier Cupissol, Gilles Calais, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2015
Everolimus for patients with metastatic renal cell carcinoma refractory to anti-VEGF therapy: results of a pooled analysis of non-interventional studiesLaurence Albiges, Ulrich Kube, Jean-Christophe Eymard, et al.
The Lancet. Oncology|October 19, 2007
Addition of estramustine to chemotherapy and survival of patients with castration-refractory prostate cancer: a meta-analysis of individual patient dataKarim Fizazi, Aurelie Le Maitre, Gary Hudes, et al.
BJU International|March 17, 2010
Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre studyJean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, et al.
Chest|June 18, 2002
Intrapleural infusion of activated macrophages and gamma-interferon in malignant pleural mesothelioma: a phase II studyIsabelle Monnet, Jean-Luc Breau, Denis Moro, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 12, 2017
A prospective observational study on the evaluation of everolimus-related adverse events in metastatic renal cell carcinoma after first-line anti-vascular endothelial growth factor therapy: the AFINITE study in FranceFlorence Joly, Jean-Christophe Eymard, Laurence Albiges, et al.
Cancers|January 11, 2022
Identification of Neoadjuvant Chemotherapy Response in Muscle-Invasive Bladder Cancer by Fourier-Transform Infrared Micro-ImagingCamille Mazza, Vincent Gaydou, Jean-Christophe Eymard, et al.
JAMA|May 19, 2005
Life-threatening sepsis associated with adjuvant doxorubicin plus docetaxel for intermediate-risk breast cancerEtienne G C Brain, Thomas Bachelot, Daniel Serin, et al.
American Journal of Clinical Oncology|December 13, 2002
Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcomaXavier Pivot, Christine Chevreau, Didier Cupissol, et al.
Pageof 7